Literature DB >> 23223598

Coccidioidomycosis acquired in Washington State.

Nicola Marsden-Haug1, Marcia Goldoft, Cindy Ralston, Ajit P Limaye, Jimmy Chua, Heather Hill, Larry Jecha, George R Thompson, Tom Chiller.   

Abstract

Clinical, laboratory, and epidemiologic evidence suggest that 3 individuals with acute coccidioidomycosis were exposed in Washington State, significantly beyond previously identified endemic areas. Given the patients' lack of recent travel, coccidioidomycosis was not suspected, leading to delays in diagnosis and appropriate therapy. Clinicians should be aware of this possibility and consider the diagnosis.

Entities:  

Mesh：

Year:  2012        PMID： 23223598     DOI： 10.1093/cid/cis1028

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  47 in total

Review 1.  Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks.

Authors:  Kaitlin Benedict; Malcolm Richardson; Snigdha Vallabhaneni; Brendan R Jackson; Tom Chiller
Journal:  Lancet Infect Dis       Date:  2017-07-31       Impact factor: 25.071

2.  CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against Coccidioides posadasii Infection.

Authors:  Althea Campuzano; Hao Zhang; Gary R Ostroff; Lucas Dos Santos Dias; Marcel Wüthrich; Bruce S Klein; Jieh-Juen Yu; Humberto H Lara; Jose L Lopez-Ribot; Chiung-Yu Hung
Journal:  J Immunol       Date:  2020-05-01       Impact factor: 5.422

3.  Cutaneous manifestations of endemic mycoses.

Authors:  Jeannina A Smith; James Riddell; Carol A Kauffman
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

4.  Fungal infections of the central nervous system.

Authors:  Claire S Jacobs; Mark R Etherton; Jennifer L Lyons
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 5.  Update on the Epidemiology of coccidioidomycosis in the United States.

Authors:  Orion Z McCotter; Kaitlin Benedict; David M Engelthaler; Ken Komatsu; Kimberley D Lucas; Janet C Mohle-Boetani; Hanna Oltean; Duc Vugia; Tom M Chiller; Gail L Sondermeyer Cooksey; Alyssa Nguyen; Chandler C Roe; Charlotte Wheeler; Rebecca Sunenshine
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

6.  Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease.

Authors:  George R Thompson; David A Stevens; Karl V Clemons; Josh Fierer; Royce H Johnson; Jane Sykes; George Rutherford; Michael Peterson; John W Taylor; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2014-10-16       Impact factor: 2.574

7.  Hospitalized burden and outcomes of coccidioidomycosis: A nationwide analysis, 2005-2012.

Authors:  Ruihong Luo; Alan Greenberg; Christian D Stone
Journal:  Med Mycol       Date:  2017-06-01       Impact factor: 4.076

Review 8.  Coccidioidal Meningitis: A Review on Diagnosis, Treatment, and Management of Complications.

Authors:  Royce Johnson; Jackie Ho; Pete Fowler; Arash Heidari
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-13       Impact factor: 5.081

9.  Soil and climactic predictors of canine coccidioidomycosis seroprevalence in Washington State: An ecological cross-sectional study.

Authors:  Julianne Meisner; Wayne R Clifford; Ron D Wohrle; Dave Kangiser; Peter Rabinowitz
Journal:  Transbound Emerg Dis       Date:  2019-06-19       Impact factor: 5.005

10.  Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.

Authors:  Lisa F Shubitz; Daniel A Powell; Hien T Trinh; M Lourdes Lewis; Marc J Orbach; Jeffrey A Frelinger; John N Galgiani
Journal:  Vaccine       Date:  2018-04-30       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.